AU4807990A - Antinephrotoxic perfusion solution - Google Patents

Antinephrotoxic perfusion solution

Info

Publication number
AU4807990A
AU4807990A AU48079/90A AU4807990A AU4807990A AU 4807990 A AU4807990 A AU 4807990A AU 48079/90 A AU48079/90 A AU 48079/90A AU 4807990 A AU4807990 A AU 4807990A AU 4807990 A AU4807990 A AU 4807990A
Authority
AU
Australia
Prior art keywords
antinephrotoxic
perfusion solution
cytostatic
kidneys
protect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48079/90A
Inventor
Hagen Bertermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SKREZEK CHRISTIAN
Original Assignee
SKREZEK CHRISTIAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SKREZEK CHRISTIAN filed Critical SKREZEK CHRISTIAN
Publication of AU4807990A publication Critical patent/AU4807990A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Use of a mixture of various L-amino acids to protect the kidneys from toxic damage due to cytostatic and immunosuppressive drugs.
AU48079/90A 1988-12-22 1989-12-21 Antinephrotoxic perfusion solution Abandoned AU4807990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3843241A DE3843241A1 (en) 1988-12-22 1988-12-22 NEPHROPROTECTIVE INFUSION SOLUTION
DE3843241 1988-12-22

Publications (1)

Publication Number Publication Date
AU4807990A true AU4807990A (en) 1990-07-10

Family

ID=6369857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48079/90A Abandoned AU4807990A (en) 1988-12-22 1989-12-21 Antinephrotoxic perfusion solution

Country Status (8)

Country Link
EP (1) EP0408691B1 (en)
JP (1) JPH078790B2 (en)
AT (1) ATE110570T1 (en)
AU (1) AU4807990A (en)
DE (2) DE3843241A1 (en)
ES (1) ES2063332T3 (en)
RU (1) RU2077883C1 (en)
WO (1) WO1990006769A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094813A1 (en) * 2004-03-31 2005-10-13 Ajinomoto Co., Inc. Medicine for kidney disorder
US9669010B2 (en) 2012-12-06 2017-06-06 Bio Health Solutions, Llc Treatment for chronic kidney disease
EP2928461B1 (en) * 2012-12-06 2019-08-21 Bio Health Solutions, LLC Treatment for chronic kidney disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414491A1 (en) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-Amino acid mixtures for parenteral and oral use for kidney disorders

Also Published As

Publication number Publication date
RU2077883C1 (en) 1997-04-27
ATE110570T1 (en) 1994-09-15
EP0408691B1 (en) 1994-08-31
DE3843241C2 (en) 1990-11-22
ES2063332T3 (en) 1995-01-01
DE3843241A1 (en) 1990-06-28
EP0408691A1 (en) 1991-01-23
JPH078790B2 (en) 1995-02-01
DE58908288D1 (en) 1994-10-06
JPH03502805A (en) 1991-06-27
WO1990006769A1 (en) 1990-06-28

Similar Documents

Publication Publication Date Title
CA2135062A1 (en) Pharmaceutical and Other Dosage Forms
GEP20001917B (en) Macrolidal Antibiotic.
IT1256450B (en) NITRIC ESTERS WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
AU3891889A (en) Cardioplegia administration set
DE69426984D1 (en) MEDICINE PREPARATION
NZ335146A (en) N-(N'-substituted glycyl)-2-cyanopyrrolidine derivatives and medicaments
IL89165A0 (en) Five-membered ring systems with bonded azacyclic ring substituents,their preparation and pharmaceutical compositions containing them
IL74497A0 (en) Pharmaceutical compositions and phenyl carbamate derivatives
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
ES2013129A6 (en) Deprenyl for systemic transdermal administration.
AU588968B2 (en) Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
ES2001855A6 (en) 1-Substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents.
MY101784A (en) Novel pharmacological compounds
AU1795383A (en) Pharmaceutical preparations having analgetic and cytostatic activity
DK627987A (en) PHARMACEUTICAL PREPARATIONS
AU4807990A (en) Antinephrotoxic perfusion solution
DE3867086D1 (en) BENZOTHIEPINO (5,4-C) PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL EFFECTS.
DK142789A (en) MIXTURE OF ALGINATES AND POLYACRYLATES AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS
AU4581089A (en) N-substituted 2-cyano-3-oxo-3-substituted-proprionamides as anti-inflammatory agents
ES2001290A6 (en) (+)-6-Chloro-5,10-dihydro-5- not (1-methyl-4-piperidinyl)acetyl -11H-dibenzo not b,e not 1,4 diazepin-11-one, its isolation and its use as a medicament
DE2965364D1 (en) Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
AU3474289A (en) Pharmaceutical solutions of triamterene
DE3671630D1 (en) GLYCERO-3 (2) -PHOSPHO-L-SERINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
ES8500280A1 (en) Ergot alkaloids, manufacturing process thereof and pharmaceutical preparations containing them